Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Receivables (2016 - 2025)

Historic Receivables for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $185.8 million.

  • Cross Country Healthcare's Receivables fell 4052.87% to $185.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.8 million, marking a year-over-year decrease of 4052.87%. This contributed to the annual value of $232.5 million for FY2024, which is 4970.43% down from last year.
  • Latest data reveals that Cross Country Healthcare reported Receivables of $185.8 million as of Q3 2025, which was down 4052.87% from $213.1 million recorded in Q2 2025.
  • Over the past 5 years, Cross Country Healthcare's Receivables peaked at $927.1 million during Q1 2022, and registered a low of $185.8 million during Q3 2025.
  • Its 5-year average for Receivables is $475.2 million, with a median of $422.9 million in 2021.
  • Its Receivables has fluctuated over the past 5 years, first surged by 25190.8% in 2022, then crashed by 4989.36% in 2024.
  • Cross Country Healthcare's Receivables (Quarter) stood at $633.9 million in 2021, then rose by 2.39% to $649.0 million in 2022, then fell by 28.78% to $462.3 million in 2023, then tumbled by 49.7% to $232.5 million in 2024, then fell by 20.07% to $185.8 million in 2025.
  • Its last three reported values are $185.8 million in Q3 2025, $213.1 million for Q2 2025, and $281.7 million during Q1 2025.